US Stock MarketDetailed Quotes

GPCR Structure Therapeutics

Watchlist
  • 24.390
  • +0.020+0.08%
Close Feb 14 16:00 ET
  • 24.900
  • +0.510+2.09%
Post 19:56 ET
1.40BMarket Cap-12.63P/E (TTM)

About Structure Therapeutics Company

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in South San Francisco, CA.

Company Profile

SymbolGPCR
Company NameStructure Therapeutics
Listing DateFeb 3, 2023
Issue Price15.00
Founded2019
CEOProfessor Raymond C. Stevens, PhD
MarketNASDAQ
Employees93
Securities TypeDR
ADS Ratio1.0 : 3.0
Fiscal Year Ends12-31
Address601 Gateway Boulevard,Suite 900
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-457-1978
Websitehttp://www.structuretx.com

Company Executives

  • Name
  • Position
  • Salary
  • Professor Raymond C. Stevens, PhD
  • Director and Chief Executive Officer
  • --
  • Jun Yoon
  • Principal Accounting Officer and Chief Financial Officer
  • --
  • Dr. Yingli Ma, PhD
  • Chief Technology Officer
  • --
  • Dr. Blai Coll
  • Chief Medical Officer
  • --
  • Ashley F. Hall, J.D.
  • Chief Development Officer
  • --
  • Dr. Xichen Lin, PhD
  • Chief Scientific Officer
  • --
  • Daniel G. Welch
  • Chairman of the Board
  • --
  • Sharon E. Tetlow
  • Independent Director
  • --
  • Angus Charles Russell
  • Independent Director
  • --
  • Dr. Joanne Waldstreicher, M.D.
  • Independent Director
  • --
  • Eric L. Dobmeier
  • Independent Director
  • --
  • Dr. Ted W. Love, M.D.
  • Independent Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
HNAC Technology
300490
+19.95%
5
Cubic Digital Technology
300344
+19.64%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Earnings Season Underway
Earnings season is here. What to know?
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!